Pre-Clinical Research Services

CMIC Chicago Laboratory Pre-Clinical Services

Pre-Clinical Services

The pre-clinical phase of drug development is a crucial stage in the journey towards bringing new therapies to market. This phase involves a comprehensive evaluation of potential drug candidates in laboratory and animal studies to assess their safety, efficacy, and pharmacokinetic properties before advancing to human clinical trials.

Pre-clinical research lays the foundation for subsequent clinical development, providing essential data and insights to guide decision-making and optimize the chances of success in later stages.

At CMIC’s Chicago Lab, we offer a wide range of pre-clinical research services designed to support our clients at every step of the drug development process.

  • Our team brings extensive experience in pre-clinical research and drug development, ensuring the highest standards of quality and reliability.
  • We tailor our services to meet the specific needs and objectives of each client, providing personalized support throughout the drug development process.
  • CMIC adheres to rigorous regulatory guidelines and industry standards to ensure the integrity and reliability of our pre-clinical research data.
  • We believe in fostering strong partnerships with our clients, working closely together to achieve shared goals and milestones.
Testing in lab

Toxicology Studies:

Our support of toxicology studies help to assess the safety profile of investigational compounds, assisting our clients in identifying and mitigating potential risks early in the development process. From acute and subchronic toxicity studies to specialized evaluations such as reproductive toxicology and carcinogenicity studies, our world-class test site delivers reliable data to inform regulatory submissions and support decision-making.

Pharmacokinetics (PK) Studies:

Understanding the pharmacokinetic profile of a drug candidate is essential for optimizing dosing regimens and predicting its behavior in humans. The data we generate provide valuable insights into the absorption, distribution, metabolism, and excretion (ADME) of compounds in various animal models. With our state-of-the-art facilities and expertise in bioanalytical techniques, we generate high-quality PK and ADA data to guide dose selection, formulation optimization, and overall drug development strategy.

In Vitro Studies:

In vitro studies offer a controlled environment for evaluating compound activity, toxicity, and mechanism of action. At CMIC, we offer a comprehensive suite of in vitro assays and screening services to support our clients’ drug development efforts. Our customizable solutions provide valuable insights into compound behavior and efficacy, helping our clients identify promising drug candidates and optimize their therapeutic potential.

Partner with CMIC Group

Have inquiries about our services or are you interested in outsourcing your operations to us?